Cirugía
Departamento
CARLOS JUAN
LUMBRERAS BERMEJO
Profesor titular de universidad
Publicaciones en las que colabora con CARLOS JUAN LUMBRERAS BERMEJO (37)
2024
-
Impact of a Hospitalist Co-Management Program on Medical Complications and Length of Stay in Neurosurgical Patients
Joint Commission Journal on Quality and Patient Safety
2023
-
Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19
Kidney International Reports, Vol. 8, Núm. 8, pp. 1514-1530
-
Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 5
2022
2021
-
Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study
Liver Transplantation, Vol. 27, Núm. 6, pp. 913-917
2020
-
COVID-19 in solid organ transplant recipients: A single-center case series from Spain
American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858
-
Varied clinical presentation and outcome of SARS-CoV-2 infection in liver transplant recipients: Initial experience at a single center in Madrid, Spain
Transplant Infectious Disease, Vol. 22, Núm. 5
2016
-
Infectious Complications Following Small Bowel Transplantation
American Journal of Transplantation, Vol. 16, Núm. 3, pp. 951-959
2015
-
Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease
Journal of Infection, Vol. 71, Núm. 5, pp. 561-570
-
Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients
Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646
2013
-
Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation
Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139
-
Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation
Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415
-
Limited impact of cytomegalovirus infection in the long-term outcome of renal and liver transplant
Journal of Clinical Virology, Vol. 56, Núm. 4, pp. 316-322
2009
-
Incidence, risk factors, and outcome of chronic rejection during antiviral therapy for posttransplant recurrent hepatitis C
Liver Transplantation, Vol. 15, Núm. 8, pp. 948-955
2006
-
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
Liver Transplantation, Vol. 12, Núm. 12, pp. 1805-1812
2005
-
Advanced donor age increases the risk of severe recurrent hepatitis C after liver transplantation
Transplant International, Vol. 18, Núm. 8, pp. 902-907
2004
-
Eficacia del tratamiento anticipado con ganciclovir en la prevención de la enfermedad por citomegalovirus en receptores de un trasplante de hígado
Medicina Clinica, Vol. 122, Núm. 2, pp. 41-45
2002
-
Successful treatment of mucor infection after liver or pancreas-kidney transplantation
Transplantation, Vol. 73, Núm. 3, pp. 476-480
-
Treatment of mucor infection after liver or pancreas-kidney transplantation
Transplantation Proceedings, Vol. 34, Núm. 1, pp. 82-83
2001
-
Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989
Hepato-Gastroenterology, Vol. 48, Núm. 41, pp. 1435-1442